Dan Cohen, MD, PhD
- 9Articles
- 25.1KReads
- 2004–2017Active
- 30Collaborators
- 259Citations
About
Dan Cohen, MD, PhD, has contributed extensively to psychiatry literature from 2004 to 2017, focusing on schizophrenia and schizoaffective disorders, mood disorders, and associated metabolic complications. His publications address therapeutic drug monitoring of clozapine, metabolic risks such as diabetes mellitus linked to antipsychotic treatments, and screening methods during antipsychotic therapy. Cohen's work also explores the interplay between psychiatric conditions and cardiovascular risk factors, often collaborating with authors like Christoph U. Correll and Ronald P. Stolk.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
